Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Blood Advances
|
January 4, 2018
Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia
Kamira Maharaj, Eva Sahakian, Javier Pinilla-Ibarz
Frontiers in Immunology
|
August 18, 2022
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
Kamira Maharaj, Angimar Uriepero, Eva Sahakian, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
May 22, 2025
Correction to: Evaluation of a pilot cancer patient navigation program in the limited‑resource setting of Trinidad and Tobago
Kimberly Badal, Nalisha Monroe, Alisha Mohamed, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
November 15, 2024
Correction: Evaluation of a pilot cancer patient navigation program in the limited-resource setting of Trinidad and Tobago
Kimberly Badal, Nalisha Monroe, Alisha Mohamed, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
September 24, 2024
A Cancer Patient Navigation Training Program for Limited-Resource Settings: Results from 5 Years of Training
Kimberly Badal, Nalisha Monroe, Alisha Mohamed, et al.
Frontiers in Immunology
|
December 17, 2020
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
Kamira Maharaj, John J Powers, Melanie Mediavilla-Varela, et al.
Blood Advances
|
November 15, 2018
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
Kamira Maharaj, John J Powers, Alex Achille, et al.
Blood Advances
|
July 8, 2020
The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells
Kamira Maharaj, John J Powers, Alex Achille, et al.
Blood Advances
|
February 12, 2025
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model
Wael Gamal, Nienke B Goedhart, Helga Simon-Molas, et al.
Gynecologic Oncology
|
April 30, 2023
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma
Katelyn F Handley, Sumit Mehta, Alexandra L Martin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Blood Advances
|
January 4, 2018
Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia
Kamira Maharaj, Eva Sahakian, Javier Pinilla-Ibarz
Frontiers in Immunology
|
August 18, 2022
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
Kamira Maharaj, Angimar Uriepero, Eva Sahakian, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
May 22, 2025
Correction to: Evaluation of a pilot cancer patient navigation program in the limited‑resource setting of Trinidad and Tobago
Kimberly Badal, Nalisha Monroe, Alisha Mohamed, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
November 15, 2024
Correction: Evaluation of a pilot cancer patient navigation program in the limited-resource setting of Trinidad and Tobago
Kimberly Badal, Nalisha Monroe, Alisha Mohamed, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
September 24, 2024
A Cancer Patient Navigation Training Program for Limited-Resource Settings: Results from 5 Years of Training
Kimberly Badal, Nalisha Monroe, Alisha Mohamed, et al.
Frontiers in Immunology
|
December 17, 2020
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
Kamira Maharaj, John J Powers, Melanie Mediavilla-Varela, et al.
Blood Advances
|
November 15, 2018
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
Kamira Maharaj, John J Powers, Alex Achille, et al.
Blood Advances
|
July 8, 2020
The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells
Kamira Maharaj, John J Powers, Alex Achille, et al.
Blood Advances
|
February 12, 2025
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model
Wael Gamal, Nienke B Goedhart, Helga Simon-Molas, et al.
Gynecologic Oncology
|
April 30, 2023
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma
Katelyn F Handley, Sumit Mehta, Alexandra L Martin, et al.
Page
of 2